omniture
logo
Search
德昇济医药（无锡）有限公司
Media Room

Latest News

rss

D3 Bio, Inc. Announces FDA Breakthrough Therapy Designation and Orphan Drug Designation for D3S-001 for the Treatment of Patients with KRAS G12C-Mutated Cancers

* Breakthrough Therapy Designation was granted for the treatment of adult patients with KRAS G12C...

2025-08-28 21:00 3089